{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:26:29Z","timestamp":1780557989569,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["K23GM147350"],"award-info":[{"award-number":["K23GM147350"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002319"],"award-info":[{"award-number":["UL1 TR002319"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.japh.2023.10.005","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:35:18Z","timestamp":1697196918000},"page":"283-289.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2\u00a0years of hormone therapy"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4825-7773","authenticated-orcid":false,"given":"Alin","family":"Kalayjian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaeleb","family":"Laszlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3789-9427","authenticated-orcid":false,"given":"Molly","family":"Fassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9643-3588","authenticated-orcid":false,"given":"Zachary","family":"Schonrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8600-6442","authenticated-orcid":false,"given":"Kikka E.","family":"Delarose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton D.","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9115-1060","authenticated-orcid":false,"given":"Lauren R.","family":"Cirrincione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.japh.2023.10.005_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2016.303578","article-title":"Transgender population size in the United States: a meta-regression of population-based probability samples","volume":"107","author":"Meerwijk","year":"2017","journal-title":"Am J Public Health"},{"key":"10.1016\/j.japh.2023.10.005_bib2","doi-asserted-by":"crossref","first-page":"43503","DOI":"10.1146\/annurev-publhealth-052620-100313","article-title":"Health and health care among transgender adults in the United States","volume":"43","author":"Scheim","year":"2022","journal-title":"Annu Rev Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2023.10.005_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"4","key":"10.1016\/j.japh.2023.10.005_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/HRP.0000000000000373","article-title":"Psychopharmacological considerations for gender-affirming hormone therapy","volume":"31","author":"Kim","year":"2023","journal-title":"Harv Rev Psychiatr"},{"issue":"5","key":"10.1016\/j.japh.2023.10.005_bib5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2105\/AJPH.2013.301241","article-title":"Stigma, mental health, and resilience in an online sample of the US transgender population","volume":"103","author":"Bockting","year":"2013","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.japh.2023.10.005_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/lgbt.2018.0221","article-title":"Trends in mental health care Use in Medicare from 2009 to 2014 by gender minority and disability status","volume":"6","author":"Progovac","year":"2019","journal-title":"LGBT Health"},{"issue":"8","key":"10.1016\/j.japh.2023.10.005_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1176\/appi.ajp.2019.19010080","article-title":"Reduction in mental health treatment utilization among transgender individuals after gender-affirming surgeries: a total population study","volume":"177","author":"Br\u00e4nstr\u00f6m","year":"2020","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.japh.2023.10.005_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jad.2019.04.018","article-title":"Psychotropic polypharmacy reconsidered: between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders","volume":"252","author":"Rhee","year":"2019","journal-title":"J\u00a0Affect Disord"},{"issue":"2","key":"10.1016\/j.japh.2023.10.005_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.pra.0000265766.25495.3b","article-title":"Polypharmacy: when is it rational?","volume":"13","author":"Preskorn","year":"2007","journal-title":"J\u00a0Psychiatr Pract"},{"issue":"8","key":"10.1016\/j.japh.2023.10.005_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11910-022-01208-4","article-title":"Epilepsy care in transgender patients","volume":"22","author":"Waldman","year":"2022","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.japh.2023.10.005_bib11","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/epi.13597","article-title":"Hormone replacement therapy with estrogens may reduce lamotrigine serum concentrations: a matched case\u2013control study","volume":"58","author":"Reimers","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.japh.2023.10.005_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2015.03.006","article-title":"Interactions between hormonal contraception and antiepileptic drugs: clinical and mechanistic considerations","volume":"28","author":"Reimers","year":"2015","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.japh.2023.10.005_bib13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/10600280211050120","article-title":"A\u00a0retrospective analysis of Creatinine-based Kidney function with and without sex Assigned at Birth among transgender adults","volume":"56","author":"Fadich","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1016\/j.japh.2023.10.005_bib14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/jamia\/ocy022","article-title":"Using clinician text notes in electronic medical record data to validate transgender-related diagnosis codes","volume":"25","author":"Blosnich","year":"2018","journal-title":"J\u00a0Am Med Inf Assoc"},{"issue":"3","key":"10.1016\/j.japh.2023.10.005_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.annepidem.2016.01.004","article-title":"A\u00a0novel method for estimating transgender status using electronic medical records","volume":"26","author":"Roblin","year":"2016","journal-title":"Ann Epidemiol"},{"issue":"2","key":"10.1016\/j.japh.2023.10.005_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jamia\/ocab136","article-title":"Transgender data collection in the electronic health record: current concepts and issues","volume":"29","author":"Kronk","year":"2022","journal-title":"J\u00a0Am Med Inf Assoc"},{"issue":"9596","key":"10.1016\/j.japh.2023.10.005_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.japh.2023.10.005_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National Trends in psychotropic medication polypharmacy in office-based Psychiatry","volume":"67","author":"Mojtabai","year":"2010","journal-title":"Arch Gen Psychiatr"},{"issue":"2","key":"10.1016\/j.japh.2023.10.005_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36512","article-title":"Prevalence and Co-occurrence of alcohol, nicotine, and other substance use disorder diagnoses among US transgender and Cisgender adults","volume":"4","author":"Hughto","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.japh.2023.10.005_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.amepre.2016.02.018","article-title":"Trends in use of medications for smoking cessation in Medicare, 2007-2012","volume":"51","author":"Jarlenski","year":"2016","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.japh.2023.10.005_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40801-019-0153-5","article-title":"Prevalence of psychotropic polypharmacy and associated healthcare resource utilization during initial phase of care among adults with Cancer in USA","volume":"6","author":"Aroke","year":"2019","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.japh.2023.10.005_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jad.2016.12.001","article-title":"Psychopharmacological drug utilization patterns in pregnant women with bipolar disorder - a nationwide register-based study","volume":"210","author":"Broeks","year":"2017","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.japh.2023.10.005_bib23","series-title":"Deutsch MB Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People","year":"2016"},{"issue":"6","key":"10.1016\/j.japh.2023.10.005_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287575","article-title":"Retrospective cohort observation on psychotropic drug-drug interaction and identification utility from 3 databases: drugs.com\u00ae, Lexicomp\u00ae, and Epocrates\u00ae","volume":"18","author":"Pinkoh","year":"2023","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.japh.2023.10.005_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatr"},{"issue":"2","key":"10.1016\/j.japh.2023.10.005_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1016\/j.japh.2023.10.005_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/M22-2056","article-title":"Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder: a living clinical guideline from the American College of Physicians","volume":"176","author":"Qaseem","year":"2023","journal-title":"Annals of internal medicine"},{"issue":"S1","key":"10.1016\/j.japh.2023.10.005_bib29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/hup.915","article-title":"Cardiac side effects of psychiatric drugs","volume":"23","author":"Mackin","year":"2008","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.japh.2023.10.005_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/273060","article-title":"Minimizing cardiovascular adverse effects of atypical antipsychotic drugs in patients with schizophrenia","volume":"2014","author":"Khasawneh","year":"2014","journal-title":"Cardiol Res Pract"},{"issue":"11","key":"10.1016\/j.japh.2023.10.005_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003821","article-title":"Drug-induced orthostatic hypotension: a systematic review and meta-analysis of randomised controlled trials","volume":"18","author":"Bhanu","year":"2021","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.japh.2023.10.005_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jamapsychiatry.2022.0662","article-title":"Psychopharmacologic considerations for transgender and gender diverse people","volume":"79","author":"Turban","year":"2022","journal-title":"JAMA Psychiatr"},{"issue":"7","key":"10.1016\/j.japh.2023.10.005_bib33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tips.2022.03.006","article-title":"Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine","volume":"43","author":"Le","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.japh.2023.10.005_bib34","first-page":"19","article-title":"Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review","volume":"127","author":"Fornaro","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"10.1016\/j.japh.2023.10.005_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1176\/appi.ps.201500482","article-title":"Off-label prescribing of psychotropic medication, 2005\u20132013: an Examination of potential Influences","volume":"68","author":"O\u2019Brien","year":"2017","journal-title":"Psychiatr Serv"},{"issue":"9","key":"10.1016\/j.japh.2023.10.005_bib36","first-page":"678","article-title":"Treatment of functional GI disorders with psychotropic Medicines: a review of Evidence with a Practical approach","volume":"2","author":"Thiwan","year":"2006","journal-title":"Gastroenterol Hepatol"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123003126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123003126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:54:04Z","timestamp":1761544444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319123003126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1544319123003126"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.10.005","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2\u00a0years of hormone therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}